← Leaderboards
Xuri Li
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyNeurobiologyNeovascularGrowth FactorAngiogenesis InhibitorsRetinalRetinal DegenerationBlood VesselsNeuroprotectionEye DiseasesVascular Endothelial Growth FactorsEye DevelopmentCell ProliferationMolecularLoss Of FunctionOlder PopulationBlindnessComplicationHuman DiseaseNeutralizing AntibodyGenesNeurodegenerative DisordersGene DeliveryGain Of Function
Grant awards (6)
Angiogenic and neuroprotective molecules in ocular physiology and pathology$1,047,086
ZIA · FY2012 · EY · contact PI
Angiogenic/neuroprotective molecules in eye diseases$1,409,461
ZIA · FY2011 · EY · contact PI
Angiogenic/neuroprotective molecules in eye diseases$1,342,304
ZIA · FY2010 · EY · contact PI
Angiogenic/neuroprotective molecules in eye diseases$1,347,483
ZIA · FY2009 · EY · contact PI
Angiogenic/neuroprotective molecules in eye diseases$1,523,283
Z01 · FY2008 · EY · contact PI
VEGFs/PDGFs in Ocular Development and Diseases$1,774,036
Z01 · FY2007 · EY · contact PI